Rôle de la molécule CD81 dans le fonctionnement des lymphocytes B chez l’homme

Julie Smet; Menno van Zelm; Liliane Schandené; Brigitte Adams; Mirjam van der Burg; Françoise Mascart

doi:doi:10.1051/medsci/201127133

Accès gratuit

Numéro		Med Sci (Paris) Volume 27, Numéro 1, Janvier 2011


Page(s)		33 - 35
Section		Nouvelles
DOI		http://dx.doi.org/10.1051/medsci/201127133
Publié en ligne		10 February 2011

Eades-Perner AM, Gathmann B, Knerr V, et al. ESID registry working party. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol 2007 ; 147 : 306-312. [CrossRef] [PubMed]
Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003 ; 4 : 261-268. [CrossRef] [PubMed]
Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005 ; 37 : 829-834. [CrossRef] [PubMed]
Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 2006 ; 117 : 740-746. [CrossRef] [PubMed]
Van Zelm MC, Reisli I, Van der Burg M, et al. An antibody-deficiency syndrome due to mutation in the CD19 gene. N Engl J Med 2006 ; 354 : 1901-1912. [CrossRef] [PubMed]
Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992 ; 256 : 105-107. [CrossRef] [PubMed]
Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998 ; 16 : 89-109. [CrossRef] [PubMed]
Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998 ; 282 : 938-941. [CrossRef] [PubMed]
Silvie O, Rubinstein E, Franetich JF, et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat Med 2003 ; 9 : 93-96. [CrossRef] [PubMed]
Silvie O, Rubinstein E, Boucheix C, Mazier D. CD81: une tétraspanine impliquée dans l’infection par Plasmodium. Med Sci (Paris) 2003 ; 19 : 169-171. [PubMed]
Grigorov B, Attuil-Audenis V, Perugi F, et al. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology 2009 ; 6 : 28-43. [CrossRef] [PubMed]
Kanegane H, Agematsu K, Futatani T, et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007 ; 8 : 663-670. [CrossRef] [PubMed]
van Zelm MC, Smet J, Adams B, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010 ; 120 : 1265-1274. [CrossRef] [PubMed]

[1] Eades-Perner AM, Gathmann B, Knerr V, et al. ESID registry working party. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol 2007 ; 147 : 306-312. [CrossRef] [PubMed]

[2] Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003 ; 4 : 261-268. [CrossRef] [PubMed]

[3] Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005 ; 37 : 829-834. [CrossRef] [PubMed]

[4] Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 2006 ; 117 : 740-746. [CrossRef] [PubMed]

[5] Van Zelm MC, Reisli I, Van der Burg M, et al. An antibody-deficiency syndrome due to mutation in the CD19 gene. N Engl J Med 2006 ; 354 : 1901-1912. [CrossRef] [PubMed]

[6] Carter RH, Fearon DT. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992 ; 256 : 105-107. [CrossRef] [PubMed]

[7] Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 1998 ; 16 : 89-109. [CrossRef] [PubMed]

[8] Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998 ; 282 : 938-941. [CrossRef] [PubMed]

[9] Silvie O, Rubinstein E, Franetich JF, et al. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat Med 2003 ; 9 : 93-96. [CrossRef] [PubMed]

[10] Silvie O, Rubinstein E, Boucheix C, Mazier D. CD81: une tétraspanine impliquée dans l’infection par Plasmodium. Med Sci (Paris) 2003 ; 19 : 169-171. [PubMed]

[11] Grigorov B, Attuil-Audenis V, Perugi F, et al. A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology 2009 ; 6 : 28-43. [CrossRef] [PubMed]

[12] Kanegane H, Agematsu K, Futatani T, et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007 ; 8 : 663-670. [CrossRef] [PubMed]

[13] van Zelm MC, Smet J, Adams B, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest 2010 ; 120 : 1265-1274. [CrossRef] [PubMed]

Prix Nobel 2012